Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions

American Journal of Neuroradiology

Volumn 18, Issue 9, 1997, Pages 1695-1704

  Rand, S D ^a   Prost, R ^a   Haughton, V ^a   Mark, L ^a   Strainer, J ^a   Johansen, J ^b   Kim, T A ^a   Chetty, V K ^a   Mueller, W ^a   Meyer, G ^a   Krouwer, H ^a  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Brain neoplasms, magnetic resonance; Magnetic resonance, spectroscopy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN DISEASE; BRAIN TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; BRAIN; BRAIN DISEASES; BRAIN NEOPLASMS; CEREBRAL INFARCTION; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0031546118     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-458
2. Yamagata NT, Miller BL, McBride D, et al. In vivo proton spectroscopy of intracranial infections and neoplasms. J Neuroimaging 1994;4:23-28
3. Demaerel P, Johannik K, Van Hecke P, et al. Localized H-1 NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76
4. Miller BL, McBride D, Riedy G, Caron M, Lipcamon J, O'Brien D. Changes in brain choline in tumors with H-1 NMR spectroscopy. Bull Clin Neurosci 1990;55:115-122
5. Sijens PE, Knopp MV, Brunetti A, et al. H-1 MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med 1995;33:818-826
6. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172: 541-548
7. Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593-1603
8. Segebarth CM, Baleriaux DF, Luyten PR, den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by H-1 NMR spectroscopic imaging. Magn Reson Med 1990; 13:62-76
9. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752
10. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686
11. Prost RW, Mark L, Mewissen M, Li S. Detection of glutamate/ glutamine resonances by H-1 magnetic resonance spectroscopy at 0.5 tesla. Magn Reson Med 1997;37:615-618
12. Dawson-Saunders B, Trapp RG. Basic & Clinical Biostatistics. 2nd ed. Norwalk, Conn: Appleton & Lange; 1994:213
13. Fisher LD, van Belle G. Biostatistics: A Method for the Health Sciences. New York, NY: Wiley; 1993:206-209, 256-259
14. McNeil BJ, Keeler E, Adelstein SJ. Primer on certain elements of medical decision making. N Engl J Med 1975;293:211-215
15. Swets JA, Pickett RM, Whitehead SF, et al. Assessment of diagnostic technologies. Science 1979;205:753-759
16. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36
17. Cousins JP. Clinical MR spectroscopy: fundamentals, current applications, and future potential. AJR Am J Roentgenol 1995;164: 1337-1347
18. Sorby WA. An evaluation of magnetic resonance imaging at the Royal North Shore Hospital of Sydney, 1986-1987. Med J Aust 1989;151:8-18
19. Orrison WW, Stimac GK, Stevens EA, et al. Comparison of CT, low-field-strength MR imaging, and high-field-strength MR imaging: work in progress. Radiology 1991;181:121-127
20. Haughton VM, Rimm AA, Sobocinski KA, et al. A blinded clinical comparison of MR imaging and CT in neuroradiology. Radiology 1986;160:751-755
21. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30: 424-437
22. Toft P, Leth H, Lou HC, Pryds O, Henriksen O. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J Magn Reson Imaging 1994;4:674-680
23. Kruse BK, Barker PB, van Zijl PCM, Duyn JH, Moonen CTW, Moser HW. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol 1994;36: 595-608
24. Ross BD, Moats R, Michaelis T, Mandingo JC. Neurospectroscopy. In: Introductory and Advanced MRI: Techniques and Clinical Applications. Berkeley, Calif: Society of Magnetic Resonance; 1994:120-126
25. Ross BD, Lee JH, Moats RA. Clinical MRS for clinical radiologists. In: Clinical MR Refresher Course. Berkeley, Calif: Society of Magnetic Resonance; 1993:109-115
26. Chiang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197:525-531
27. Brenner RE, Munro PMG, Williams SCR, et al. The proton NMR spectrum in acute EAE: the significance of the change in the cho:cr ratio. Magn Reson Med 1993;29:737-745
28. Roser W, Hagberg G, Mader I, et al. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 1995;33:811-817
29. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of the disease. Magn Reson Med 1990;14:154-159
30. Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993;33:18-27
31. Franzini A, Leocata F, Giorgi C, Allegranza A, Servello D, Broggi G. Role of stereotactic biopsy in multifocal brain lesions: considerations in 100 consecutive cases. J Neurol Neurosurg Psychiatry 1994;57:957-960